← All trials
NCT04518345
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 5, 2020
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2022
- First posted
- Aug 19, 2020
- Last posted
- Nov 27, 2020
- Enrollment
- 46
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ohio State UniversityLead sponsor
- Ohio State UniversitySponsor investigator
- Ohio State UniversityOverall official - principal investigator
- SumitomoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.